Skip to main content
SINPHAR logo

SINPHAR — Investor Relations & Filings

Ticker · 1734 ISIN · TW0001734002 TW Manufacturing
Filings indexed 1,611 across all filing types
Latest filing 2022-03-30 Fund Information / Fact…
Country TW Taiwan
Listing TW 1734

About SINPHAR

www.sinphar.com

Sinphar Pharmaceutical Co., Ltd. is a vertically integrated pharmaceutical group specializing in the research, development, manufacturing, and distribution of therapeutic medicines, nutraceuticals, and medical cosmetics. Established in 1977, the company produces a diverse range of products, including Western and Chinese pharmaceuticals, specialized oncology drugs, and health supplements. Sinphar operates advanced R&D facilities and an ISO 17025-certified laboratory, leveraging high-precision technology for product innovation and quality assurance. Its business model encompasses proprietary brand management alongside professional OEM and ODM services for international markets. Key areas of expertise include the development of cancer treatments, functional health foods, and medical-grade skincare. Through its global marketing network and dedicated retail counters, Sinphar provides comprehensive healthcare solutions focused on life, health, and technology.

Recent filings

Filing Released Lang Actions
110年度財務比率
Fund Information / Factsheet Classification · 90% confidence The document contains a financial data analysis table for the company 杏輝 over three fiscal years (108年度, 109年度, 110年度). The data includes financial ratios such as debt to asset ratio, liquidity ratios, turnover ratios, profitability ratios, and cash flow ratios. The document is relatively short (1012 characters) and presents summarized financial metrics rather than detailed financial statements or narrative management discussion. There is no indication that this is a full annual or interim report, nor is it an announcement or certification. The content resembles a brief financial summary or factsheet presenting key financial data points over multiple years. Therefore, the most appropriate classification is Fund Information / Factsheet (FS).
2022-03-30 Chinese
110年第4季現金流量表
Interim / Quarterly Report Classification · 95% confidence The document contains a detailed consolidated cash flow statement for the fiscal year 110 (2021) Q4 and the previous year 109 (2020). It includes comprehensive financial data such as net profit before tax, depreciation, amortization, changes in working capital, investing and financing activities, and cash balances. The presence of actual financial statements and substantive financial data for a quarterly period indicates this is a financial report for a period shorter than a full fiscal year. The document length is 2551 characters, which is sufficient to contain detailed financial data, not just an announcement or certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR).
2022-03-30 Chinese
110年第4季綜合損益表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated comprehensive income statement with detailed financial data for the fiscal year 110 (2021) and the fourth quarter, including revenue, costs, expenses, net income, and earnings per share. The presence of substantive financial statements and analysis for a period shorter than a full fiscal year (quarterly data) indicates this is a financial report for a quarter. The document length is 2429 characters, which is relatively short but contains actual financial data, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2022-03-30 Chinese
110年第4季資產負債表
Interim / Quarterly Report Classification · 90% confidence The document contains a consolidated balance sheet with detailed financial data for the fiscal year ending December 31, 2021 (民國110年第4季). It includes comprehensive financial statement line items such as assets, liabilities, equity, and subtotals, indicating it is a substantive financial report rather than a brief announcement or certification. The length is 2951 characters, which is relatively short but the content is actual financial data, not just a notice or link to a report. The document is a quarterly or interim financial report (fourth quarter of 2021) with detailed financial statements, fitting the definition of an Interim / Quarterly Report (IR).
2022-03-30 Chinese
110年度應收帳款周轉率
Regulatory Filings Classification · 95% confidence The document is very short (281 characters) and contains a brief table of financial ratios (accounts receivable turnover and average collection days) for two fiscal years (109 and 110). There is no detailed financial statement, management discussion, or comprehensive report content. It appears to be a simple financial metric disclosure without any narrative or analysis. Given the brevity and nature of the content, it does not qualify as a full Annual Report, Interim Report, or Earnings Release. It also does not fit into categories like Board/Management Information or Legal Proceedings. The document is likely a Regulatory Filing (RNS) as a general disclosure of financial metrics without substantive report content.
2022-03-30 Chinese
110年度存貨週轉率
Regulatory Filings Classification · 90% confidence The document is very short (280 characters) and contains inventory turnover ratios and average sales days for two fiscal years (109 and 110). It includes a note about significant changes in inventory turnover rates. There is no indication of a full financial report, management discussion, or detailed analysis. The content resembles a brief factual data disclosure rather than a comprehensive report or announcement. Given the brevity and nature of the data, it is best classified as a Regulatory Filing (RNS), which serves as a fallback for miscellaneous filings that do not fit other categories.
2022-03-30 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.